When was QSimulate founded?

QSimulate was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is QSimulate located?

QSimulate is headquartered in Cambridge, United States.

Who is the current CEO of QSimulate?

Toru Shiozaki of QSimulate. They have also founded 1 company.

How many employees does QSimulate have?

As of Aug 31, 2026, the latest employee count at QSimulate is 23.

Is QSimulate a funded company?

QSimulate is a funded company, having raised a total of $11M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 09, 2019.

When was the latest funding round of QSimulate?

QSimulate's latest funding was a $***** Seed round on Nov 21, 2025, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.88B in funding in 2026 to date.

Where does QSimulate rank among its competitors?

QSimulate ranks 7th amongst 41 active competitors, of which 15 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Enveda, which secured $311M in Sep, 2026.

Who are the top competitors of QSimulate?

QSimulate's top competitors include Enveda, Kvantify and Nura Bio. Among them, Enveda secured the most recent funding round in September, 2026.

QSimulate - 2026 Company Profile, Team, Funding & Competitors

QSimulate is a seed company based in Cambridge (United States), founded in 2018 by Toru Shiozaki and Garnet Chan. It operates as a Laboratory focused on developing of quantitative simulation tools to help in quantum molecular. QSimulate has raised $11M in funding from Embark Ventures and 2xN. The company has 41 active competitors, including 15 funded and 4 that have exited. Its top competitors include companies like Enveda, Kvantify and Nura Bio.

Company Details

Website: qsimulate.com
Email ID: *****@qsimulate.com

Key Metrics

Founded Year

2018

Location

Cambridge, United States

Stage

Seed

Total Funding

$11M in 6 rounds

Latest Funding Round

Seed, Nov 21, 2025, $*****

Investors

Embark Ventures & 7 more

Ranked

7^th among 41 active competitors

Employee Count

23 as on Aug 31, 2026

Similar Companies

Enveda & 45 more

View QSimulate's full profile

QSimulate has raised a total funding of $11M over 6 rounds. Its first funding round was on Sep 09, 2019. Its latest funding round was a Seed round on Nov 21, 2025 for $*****. 1 investor participated in its latest round. QSimulate has 8 institutional investors.

Here is the list of recent funding rounds of QSimulate:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 21, 2025	3934576	Seed	5055335	1933229	3802255	6103519
Apr 21, 2025	5808223	Grant (prize money)	9302999	5277939	5084680	HHS
Mar 28, 2025	2562620	Grant (prize money)	5366957	4049908	2164393	HHS

Access funding benchmarks and valuations. Sign up today!

View details of QSimulate's funding rounds and investors

The founders of QSimulate are Toru Shiozaki and Garnet Chan. Toru Shiozaki is the CEO of QSimulate.

Here are the details of QSimulate's key team members:

Toru Shiozaki: Co-Founder & CEO of QSimulate.
Contact Info: 1 email address
Garnet Chan: Co-Founder of QSimulate.

View details of QSimulate's Founder profiles and Board Members

QSimulate's employee count trend

QSimulate has 23 employees as of Aug 26. Here is QSimulate's employee count trend over the years:

Uncover QSimulate's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of QSimulate include Enveda, Kvantify and Nura Bio. Here is the list of Top 10 competitors of QSimulate, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Enveda 2019, Boulder (United States), Series E	AI-based platform to decipher the chemistry of nature and develop new medicines	$845M	Premji Invest, Kinnevik & 36 others	63/100
2nd	Kvantify 2022, Copenhagen (Denmark), Seed	Provider of quantum computing solutions for businesses in industries such as finance, life sciences, and logistics	$18.9M	Dreamcraft Ventures, Lundbeck Foundation ... & 10 others	61/100
3rd	Nura Bio 2018, San Francisco (United States), Series B	Provider of solution for diagnosis of a neurological disorder and neuroprotective medicines	$215M	The Column Group, Sanofi Ventures & 2 others	59/100
4th	Diagonal Therapeutics 2022, Cambridge (United States), Series B	Developer of antibody therapeutics for the treatment of rare diseases	$253M	VF Partners, Atlas Venture & 16 others	55/100
5th	IMIDomics 2015, San Francisco (United States), Series A	Developer of medicines for the treatment of immune-mediated inflammatory diseases	$16.5M	DNS Capital, Evotec & 5 others	54/100
6th	revalia bio 2021, New Haven (United States), Seed	Provider of contract based drugs development services for biopharma sector	$26.8M	Sierra Ventures, AFF & 5 others	54/100
7th	QSimulate 2018, Cambridge (United States), Seed	Laboratory focused on developing of quantitative simulation tools to help in quantum molecular	$11M	Anthem Venture Partners, 2xN & 6 others	53/100
8th	Applied BioMath 2013, Cambridge (United States), Acquired	Systems biology and pharmacology modeling services to aid drug discovery and development	$2.32M	10x Venture Partners, NIH & 1 others	48/100
9th	Nimble Therapeutics 2019, Madison (United States), Acquired	Provider combinatorial chemistry-related drug discovery services	$10M	Telegraph Hill Partners, Roche & 1 others	41/100
10th	Kimia 2023, Berkeley (United States), Series A	Provider of a next generation drug discovery engine for mall molecule drugs	$55M	Horizons Ventures, The Column Group	41/100